Qiming U.S. Healthcare GP II LLC 13D/13G Filings for Tourmaline Bio, Inc. (TRML)

Qiming U.S. Healthcare GP II LLC 13D and 13G filings for Tourmaline Bio, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2023-10-30
4:15 pm
Purchase
2023-10-19 13D Tourmaline Bio, Inc.
TRML
Qiming U.S. Healthcare GP II LLC 646,770
3.200%
646,770increase
(New Position)
Filing